Roger Waltzman
Chief Tech/Sci/R&D Officer at INDAPTUS THERAPEUTICS, INC.
Profile
Roger J.
Waltzman is currently the Chief Medical Officer at Indaptus Therapeutics, Inc. He previously held positions as President & Chief Medical Officer at Napo Pharmaceuticals, Inc., Chief Scientific Officer at Jaguar Animal Health, Inc., Head-Malaria Drug Development at Novartis Pharmaceuticals Corp., and Chief Medical Officer at Inspirna, Inc. He also served as the Chief Medical Officer at Molecular Templates, Inc. from 2019 to 2023.
Dr. Waltzman has a background in undergraduate studies from Brown University, an MBA from Columbia Business School, and a doctorate from The Warren Alpert Medical School.
Roger Waltzman active positions
| Companies | Position | Start |
|---|---|---|
| INDAPTUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-08-06 |
Former positions of Roger Waltzman
| Companies | Position | End |
|---|---|---|
| MOLECULAR TEMPLATES, INC. | Chief Tech/Sci/R&D Officer | 2023-07-31 |
Jaguar Animal Health, Inc.
 Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Chief Tech/Sci/R&D Officer | 2017-04-02 |
| JAGUAR HEALTH, INC. | Chief Tech/Sci/R&D Officer | 2017-04-02 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | 2015-12-31 |
Inspirna, Inc.
 Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Chief Tech/Sci/R&D Officer | - |
Training of Roger Waltzman
| Brown University | Undergraduate Degree |
| Columbia Business School | Masters Business Admin |
| The Warren Alpert Medical School | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| MOLECULAR TEMPLATES, INC. | Health Technology |
| JAGUAR HEALTH, INC. | Health Technology |
| INDAPTUS THERAPEUTICS, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Napo Pharmaceuticals, Inc.
 Napo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Napo Pharmaceuticals, Inc. provides pharmaceutical products for gastro-intestinal disorders. The company was founded by Lisa A. Conte in November 2001 and is headquartered in San Francisco, CA. | Health Technology |
Jaguar Animal Health, Inc.
Jaguar Animal Health, Inc. Pharmaceuticals: MajorHealth Technology Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
Inspirna, Inc.
Inspirna, Inc. Pharmaceuticals: MajorHealth Technology Inspirna, Inc. operates as a clinical stage biopharmaceutical company which develops molecule and antibody cancer therapeutics. It provides drugs for melanoma, colorectal and triple-negative breast cancers. The firm identifies novel cancer targets using a microRNA based target discovery platform that enable the identification and validation of novel post-transcriptionally regulated targets. The company was founded by Masoud Tavazoie, Sohail Tavazoie, Shahram Seyedin-Noor and Saeed Tavazoie in 2010 and is headquartered in New York, NY. | Health Technology |
- Stock Market
- Insiders
- Roger Waltzman
